Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡